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Abstract 
Background: In recent years there has been a tendency of increasing of the number of antibiotic-resistant strains of microorgan-
isms as causative agents of surgical wound infections, and increasing of the number of patients who have a multiple allergy to 
antibiotics. This significantly increases the duration and cost of treatment, and puts some questions on its efficiency. Aim of our 
research is to study how the bacteriophages act as agents to deal with purulent infection in the presence of allergy to antibiotics. 
Materials and Methods: We carried out a clinical examination and treatment of 68 patients with purulent-inflammatory soft 
tissue diseases treated in the Poltava Central District Clinical Hospital in the period from 2013 to 2015. The patients age ranged 
from 18 to 60 years. The patients were divided into three groups. The first group included 25 patients in whom the treatment 
was performed with the use of antibiotics. The second group included 22 patients in whom both antibiotics and bacteriophages 
were used in the complex treatment, and the third group - 21 patients who had been identified to have multiple allergy to anti-
biotics and instead of antibiotics they were prescribed bacteriophages. We evaluated the following criteria: duration of the pain, 
local tissue edema, time of appearance of granulation and wound healing, measured leukocyte index of intoxication, microbio-
logical markers of wound contamination. 
Results: In the analysis of the treatment of 68 patients found that the results of the 1st and 3rd groups did not differ statistically 
significantly, while the 2nd group of patients who used the bacteriophages and antibiotics, we found a significant reduction of 
terms in wound healing. 
Conclusions: The study shows that bacteriophages are effective agents for treatment of purulent infection and are an alternative 
in case of impossibility of the use of antibiotics. Cooperative use of bacteriophages and antibiotics leads to more effective treat-
ment. 
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Introduction 
The problem of treatment of infected wounds of soft tis-
sues still remains far from a final solution. Recent decades 
were marked by significant achievements in the study of 
the flow of wound healing, but this has not led to a great 
reduction in the number of patients with purulent infec-
tions of the soft tissues [3]. 
Currently, patients with purulent-inflammatory diseases 
account for 35-40% of the patients of general surgical 
wards. Mortality caused by purulent infection has not de-
creased. Domination of the role of opportunistic pathogens 
in the development of purulent-inflammatory soft tissue 
diseases has reduced the effectiveness of treatment, and 
created difficulties in the drugs selection [7,15]. Natural 
resistance to antibiotics does not disappear, and the bacte-
ria are gradually improving the mechanisms of resistance 
developing new protective factors for the new groups of 
antibiotics [14]. Antibiotics provide selective background 
for the gradual spread of resistant strains of microorgan-
isms [10]. 
In addition, today we have elevation of reports about 
patients, who suffer from multiple allergy to antibiotics due 
to it wide applying [11,12], so we need to find alternative to 
antibiotic therapy as quickly as possible.  
Also, one of the important pathogenetic factors that 
slows down the wound healing is the presence of biofilm on 
the surface of microorganisms [4]. Biofilms - cell aggrega-
tions, which are surrounded from outside by extracellular 
polymeric substance, produced, at least partially, by cells 
which are within the biofilm. Bacteria in biofilms have high 
resistance to antibiotics and antibacterial agents [5]. Also, 
the researchers did not exclude the possibility of transmis-
sion of genomic information through a bacterial biofilm 
matrix, which leads to an acceleration of appearance of the 
resistant strains. And the presence in the population of 
"inactive" cells with a slower metabolism, which are also 
protected by the biofilm, is a prerequisite for re-growth and 
re-activation of bacterial agents after treatment. So, the 
problem of treatment of biofilm-associated infections is 
extremely important [8]. 
An alternative way of treatment of drug-resistant bacte-
ria is to use bacteriophages [1]. Antibiotic resistance of 
target bacteria does not affect these viruses. They can ei-
ther exist in bacteria, disrupting their metabolism (lysogenic 
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phages), or destroy bacteria (lytic phages), releasing new 
viral particles. During the study of this area of treatment is 
often argued that biofilms are impenetrable to bacterio-
phages and this limit their use, but recent studies refute 
these assumptions and demonstrate the ability of bacterio-
phages to neutralize bacterial biofilms [9]. Already studied 
some of the advantages of their use: 
• Bacteriophages are self-reproduce, as long as there 
are sensitive bacteria, and then gradually eliminated from 
the body [2]. 
• They are much more specific than most antibiotics: 
they destroy only target specific pathogenic bacteria and 
cause much less damage to normal microbial balance in the 
body. 
• The phage therapy described to have few side effects. 
• There were no cases of allergic reactions to existing 
bacteriophages. 
• Phages, especially for external use, can be made quite 
cheaply.  
• Phage can be used either independently or in combi-
nation with antibiotics to reduce the bacterial resistance 
developing. 
• Bacteriophages while self-replicating in the cells are 
spread inside the biofilm matrix and kill the bacteria that 
produce the biofilms [6]; 
• Bacteriophages can carry in their genome and express 
the genes of depolymerase enzymes production that dis-
solve biofilms; 
• Also phages infect "persistent" inactive cells, thus pre-
venting reinfection [13]. 
Therefore, in practical terms, it is important to continue 
research aimed at studying the effect of bacteriophages on 
the course of wound healing, development of algorithm of 
complex treatment of infected wounds in patients with 
multiple allergy to antibiotics, using bacteriophage.   
 
Research objectives: 
1. To investigate the dynamics of the process of wound 
healing in patients with purulent inflammation of the soft 
tissues using bacteriophages, compared with the use of 
antibiotic therapy. 
2. To determine the effectiveness of bacteriophages in 
the complex treatment of infected wounds of soft tissues in 
patients with multiple allergy to antibiotics. 
 
Materials and methods: 
We carried out a clinical examination and treatment of 68 
patients with purulent-inflammatory soft tissue diseases 
treated in the Poltava Central District Clinical Hospital in the 
period from 2013 to 2015. The patients age - from 18 to 60 
years. The patients were divided into three groups. The first 
group included 25 patients in whom the treatment was 
performed with the use of antibiotics. The second group 
included 22 patients in whom both antibiotics and bacteri-
ophages were used in the complex treatment, and the third 
group - 21 patients who had been identified to have multi-
ple allergy to antibiotics and instead of antibiotics they 
were prescribed bacteriophages.  
The main complaints of patients on admission to the de-
partment were pain in the area of pathological process, 
tissue swelling, skin hyperemia, generalized weakness, 
increased body temperature. 
Among the major causes of soft tissue purulent-
inflammatory processes 9 (37.5%) in the first group, 7 
(32.7%) in the second group and 7 (33.7%) - a third group of 
patients named a trauma, 3 (10,9%) 2 (7.7%) 2 (8.4%) – self-
treated the wounds, 3 (9.4%) 2 (5.8%) 2 (7.4%) bound their 
disease with injections of drugs, 3 (12.5%) 4 (21.2%) and 3 
(13.5%) - from insect bites and 7 (29.7%) 7 (32.7%) and 7 
(34.5%) patients could not determine the cause of the dis-
ease. 
Table 1 shows the distribution of patients according to nosological 
forms, adopted in Ukraine: 
 
Table 1. Patient's diagnosis distribution 
 
Diagnosis 
1-st group 
(n=25) 
2-nd group 
(n=22) 
3-d group 
(n=21) 
Total 
Overall % Overall % Overall % Overall % 
Phlegmon 5 20,0 4 18,2 4 19,0 13 19,1 
Abscess 6 24,0 4 18,2 5 23,8 15 22,1 
Carbuncle 4 16,0 4 18,2 4 19,0 12 17,6 
Panaritium 3 12,0 4 18,2 3 14,3 10 14,7 
Paraproctitis 3 12,0 2 9,1 2 9,5 7 10,3 
Bursal abscess 1 4,0 2 9,1 1 4,8 4 5,9 
Infected hema-
toma  
3 12,0 2 9,1 2 9,5 7 10,3 
Total 25 100 22 100 21 100 68 100 
 
Local manifestations of inflammation in patients were 
characterized by the following symptoms: pain, swelling, 
hyperemia, rise of local temperature, dysfunction, which 
was found in 100% of cases in all groups of patients. 
Absolute indications for surgery in patients was the 
presence of tumor-like formation with signs of fluctuation 
and a softening in the center. Sometimes, in cases of doubt, 
for diagnostic purposes was performed puncture, ultrasonic 
diagnosis, the results of which convinced us in the need of 
surgical intervention. 
Surgery was performed in emergency in order to open 
the infected area, to remove non-viable and necrotic tis-
sues, and create conditions for adequate drainage. All pa-
tients were operated during the first day after hospitaliza-
tion - 7 (23.4%) under local and 18 (76.6%) under general 
anesthesia in the first group, 6 (28.9%) and 16 (71.1%) - in 
the second group and 5 (26.4%) and 16 (73.6%) patients in 
the third group.  
The complex treatment of inflammatory processes of 
the patients of the first group include antibiotics (consider-
ing the sensitivity of the wound microflora), desintoxicating 
and anti-inflammatory therapy. In some cases, we added 
physiotherapy methods (hyperbaric oxygen therapy, treat-
ment of wounds with a low-energy laser, magnetic thera-
py). Patients of the second group to this complex treatment 
added local bacteriophage therapy, provided by irrigation 
and application with tampons. The patients of the third 
group who had the multiple allergy to antibiotics (diag-
nosed by scarification, intradermal test and by anamnesis), 
in complex treatment as antibacterial agents used only 
bacteriophages. 
For bacteriophage treatment we used «Sekstafag» 
which contains a mixture of phages against Staphylococcus, 
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Streptococcus, Proteus (P. vulgaris, P. mirabilis), Pseudo-
monas aeruginosa, Escherichia coli and Klebsiella pneu-
moniae. 
Determination of the effectiveness of the treatment was 
carried out by the following features: 
• Microbiological studies were carried out on the basis of 
the Poltava Regional Hospital of Infectious Diseases. We 
took microbiological samples from wounds on the first, fifth 
and tenth day of wound healing. Seeding was performed on 
agar plates and incubated in a thermostat at 37
0
C for 18-24 
hours. If there was growth, the individual colonies were 
conducted on agar plates for their further identification. 
• We carried out sensitivity of the isolated strains of micro-
organisms to antibiotics (amoxicillin, oxacillin, cefazolin, 
cefepime, gentamicin, ofloxacin, ceftriaxone, lincomycin) by 
diffusion in agar using disc method. 
• Determination of sensitivity to bacteriophages was car-
ried out by drip method. The results (a bacteriophage lytic 
activity) are reported as: «CL» – confluent lysis; «SCL» - 
semi-confluent lysis; «+++» - Single colonies in an amount 
greater than 20; «++» - Single colonies in an amount of 
from 10 to 20; «+» - Individual colonies up to 10;  «-» - No 
lysis. Considering that the therapeutic effect of the action 
of the bacteriophage can occur if the lysis of the strain zone 
is determined by «+++», the «SCL» and «CL» - the category 
of "sensitive" included all strains that had lysis indicators of 
«CL», «SCL» and «+++», to "moderately sensitive"- strains 
with a zone of lysis of «++» and «+», and to resistant («-») - 
isolates in which lysis was absent. 
• The duration of pain was determined by a questionnaire 
using a visual analogue scale of pain from 0 to 10, clinically 
efficiency showed the result of 2 points or less.  
• Evaluated the presence and dynamics of reduction of 
local edema around the wound, to its complete disappear-
ance. 
• Monitored the dynamics of wound cleaning from necrotic 
tissue and fibrin films on the wound surface, before the 
appearance of granulation tissue. 
• Studied time from the appearance of granulation tissue 
on the wound surface in the form of individual cells, until 
fulfillment of the whole wound surface. 
• Determined the time of complete wound healing in pa-
tients of all three groups. 
• Measured the Leukocyte Index of Intoxication (LII) by the 
formula of Ya.Ya. Kalf-Kalif. Normal values of LII are 1,6 ± 
0,3  
• Parallel to the isolation and identification of a pure cul-
ture of pathogens of purulent inflammatory processes, we 
performed counting of the number of colony forming units 
(CFU) in the material in order to determine the speed of the 
decontamination of infected wounds. 
 
Results 
The microbial contamination of the wound has been pre-
sented in the form of aerobic and facultative gram-positive 
cocci - Staphylococcus aureus, Staphylococcus epidermidis, 
Enterococcus Faecalis, Streptococcus Pyogenes, facultative 
anaerobic Gram-negative rods – Escherichia coli, Klebsiella 
Pneumoniae, non-fermenting Gram-negative aerobic rods - 
Pseudomonas Aeruginosa and Acinetobacter (Table 2). The 
sensitivity of microorganisms to antibiotics is given in Table 
3. The sensitivity of the microorganisms to the bacterio-
phages is shown in Table 4. 
 
Table 2. Microbial wound contamination. 
Strains 
Patient groups 
1-st group 
(n=25) 
2-nd group 
(n=22) 
3-d group 
(n=21) 
Staphylococcus aureus 7 (28%) 5 (22,73%) 6 (28,57%) 
Staphylococcus 
epidermidis 
6 (24%) 5 (22,73%) 6 (28,57%) 
Enterococcus faecalis 4 (16%) 5 (22,73%) 3 (14,3%) 
Streptococcus pyogenes 3 (12%) 3 (13,64%) 2 (9,52%) 
Escherichia coli 2 (8%) 2 (9,1%) 2 (9,52%) 
Кlebsiella pneumoniae 2 (8%) 1 (4,54%) 1 (4,76%) 
Pseudomonas 
aeruginosa 
1 (4%) - 1 (4,76%) 
Acinetobacter - 1 (4,54%) - 
 
 
Table 3. The sensitivity of microorganisms to antibiotics 
 
Table 4. The sensitivity of microorganisms to bacteriophages 
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CL 5 
(45,45%) 
5 
(45,45%) 
2 
(40%) 
- - - 
SCL 3 
(27,27%) 
3 
(27,27%) 
3 
(60%) 
2 
(50%) 
2 
(100%) 
1 
(100%) 
+++ 2 
(18,18%) 
2 
(18,18%) 
- 
2 
(50%) 
- - 
++ 1 
(9,1%) 
1 
(9,1%) 
- - - - 
+ - - - - - - 
- - - - - - - 
“CL” – confluent lysis; “SCL” – semi-confluent lysis; “+++” – Single colonies 
in an amount greater than 20; “++” – Single colonies in an amount of from 
10 to 20; “+” – Individual colonies up to 10; “–” – No lysis. 
 
Pain duration in patients of the first group was 5 ± 1,2 
days, in the second group - 4.1 ± 0.8 days (p = 0.004), and in 
the third group - 5.1 ± 1.3 days (p = 0.264). (Figure 1) 
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Staphylococcus 
aureus 
abs. 16 12 12 17 8 9 14 9 
% 88,9 66,7 66,7 94,4 44,4 50,0 77,8 50,0 
Staphylococcus 
epidermidis 
abs. 13 9 12 16 6 10 12 8 
% 76,5 52,9 70,6 94,1 35,3 58,8 70,6 47,1 
Enterococcus 
faecalis 
abs. 10 7 9 11 5 8 10 7 
% 83,3 58,3 75,0 91,7 41,7 66,7 83,3 58,3 
Streptococcus 
pyogenes 
abs. 6 4 5 8 4 7 6 4 
% 75 50 62,5 100 50 87,5 75 50 
Escherichia coli 
abs. 4 3 4 6 2 4 4 - 
% 66,7 50,0 66,7 100,0 33,3 66,7 66,7  
Кlebsiella 
pneumoniae 
abs. 3 2 2 4 2 3 3 1 
% 75 50 50 100 50 75 75 25 
Pseudomonas 
aeruginosa 
abs. 1 - 1 2 1 1 1 - 
% 50  50 100 50 50 50  
Acinetobacter 
abs. - - - - 1 1 - - 
%     100 100   
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Figure 1. Pain duration 
 
Edema of tissues in patients of the first group lasted 4.8 
± 1.1 days, in the second group - 3.3 ± 0.7 days (p <0.001), 
and in the third group - 4.9 ± 1.2 days (p = 0.345). (Figure 2) 
 
 
Figure 2. Tissue edema duration 
 
Complete wound cleaning from necrotic tissues in pa-
tients of the first group lasted 5,1 ± 1,3 days, the second 
group - 4,2 ± 0,8 days (p = 0.007), and the third group - 5,0 
± 1,4 days (p = 0.208). (Figure 3) 
 
 
Figure 3. Wound cleaning from necrotic tissues. 
 
Emergence of granulations on wound surface with in pa-
tients of the first group lasted 7,3 ± 1,3 days, of the second 
group - 6,3 ± 1,1 days (p = 0.007), of the third group - 7,4 ± 
0.96 days (p = 0.31). (Figure 4) 
 
 
Figure 4. Granulation tissue appearance. 
 
Wound healing in patients of the first group took place 
at 16,2 ± 2,1 day, of the second group - at 14,9 ± 1,7 days (p 
= 0.025), and of the third group - at 16,4 ± 2,6 day (p = 
0.189). (Figure 5) 
 
 
Figure 5. Wound healing. 
 
On the first day of wound healing in patients of the first 
group the level of Leukocyte Index of Intoxication (LII) was 
higher than normal and was 2,13 ± 0,4, the second group - 
2,07 ± 0,2, the third group - 2,17 ± 0,3, statistically signifi-
cant differences between the groups have not been record-
ed. On the seventh day LII in the first group decreased to 
1,78 ± 0,3, in the second - up to 1,44 ± 0,25, in the third – to 
1,68 ± 0,45. On the fourteenth day LII in all groups contin-
ued to decline and was in the first group - 1,38 ± 0,25, in 
the second - 1,32 ± 0,36, in the third -1.42 ± 0, 86. (Figure 6) 
 
Figure 6. Leukocyte Index of Intoxication dynamics. 
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On the first day of wound healing in the first group of 
patients the number of microorganisms in the wound area 
was 7.5 ± 2,2x10
5
 CFU/ ml, in the second group - 7,4 ± 
2,4x10
5
 CFU/ ml, in the third - 7,6 ± 2,3x10
5
 CFU/ ml and 
had no statistically significant difference between the 
groups. In the process of wound healing the number of 
microorganisms decreased significantly and was on the fifth 
day: in the first group - 2,75 ± 0,7x10
4
 CFU/ ml, in the sec-
ond - 1.0 ± 0,5x10
4
 CFU/ ml, in the third – 1,5 ± 0,4x10
4
 
CFU/ ml. When comparing these data, it is established that 
in patients who received the combined treatment with 
bacteriophage (the second and third group), level of micro-
bial contamination of wounds was significantly less than in 
patients treated with only antibiotics (the first group). 
However, a statistically significant difference between pa-
tients treated with bacteriophages in combination with 
antibiotics (the second group) and patients treated with 
bacteriophages without antibiotics (group 3) - have not 
been recorded. On the tenth day of wound healing in the 
first group of patients the number of microorganisms in the 
wound was - 1,0 ± 0,5x10
3
 CFU/ ml, in the second - 0,5 ± 
0,4x10
3
 CFU/ ml, in the third - 0,5 ± 0,3x10
3
. After compar-
ing the data between all groups it was established that 
patients of the second and third group had less level of 
microbial wound contamination (Table 5). 
 
Table 5. Levels of wound contamination 
Patient groups 
Day of wound healing 
1-st 5-th 10-th 
1-st group (n=25) 7,5±2,2х105 2,75±0,7х104 1,0±0,5х103 
2-nd group (n=22) 7,4±2,4х105 1,0±0,5х104 0,5±0,4х103 
3-d group (n=21) 7,6±2,3х105 1,5±0,4х104 0,5±0,3 х103 
р-value 
1 0,882 <0,001 <0,001 
2 0,881 <0,001 <0,001 
3 0,782 0,156 <0,001 
Note: 
p1 - the level of statistical significance between the first and second groups of patients, 
p2 - the level of statistical significance between the first and third groups of patients, 
p3 - the level of statistical significance between the second and third groups of patients. 
 
Discussion 
After analyzing the clinical and microbiological results of the 
study, changes in the wound healing process, we found that 
patients who were additionally included bacteriophage in 
treatment, compared to patients treated with only antibiot-
ics, pain duration was less than an average for 0.9 days (p = 
0.004), tissue swelling – less for 1.5 days (p<0.001), wound 
cleaning occurred faster by 0.9 days (p = 0.007), the emer-
gence of active granulation - 1.0 days (p = 0.007) wound 
healing - by 1.3 days (p = 0.025). Thus, the use of bacterio-
phages in treatment leads in all patients to a statistically 
significant reduction in pain and edema syndrome, acceler-
ating wound cleaning, granulation formation, wound con-
traction and wound healing. 
All the patients in the treatment process had a gradual 
decrease of the level of Leukocyte Index of Intoxication, 
with its normalization on the seventh and fourteenth day. 
However, in patients who received the combined treatment 
with bacteriophage as compared to patients treated with 
only antibiotics, LII level was reduced by 19.1% (p <0.001) 
on the seventh day and by 4,3% (p = 0,14) to a fourteenth 
day. 
The analysis of the dynamics of changes LII proves that 
the use of bacteriophage in the combined treatment result-
ed in a statistically significant reduction in LII (the seventh 
day) compared with patients who received only traditional 
treatment, which indicates a decrease in endogenous intox-
ication while using the proposed method of treatment. 
In the process of wound healing in patients who re-
ceived the combined treatment of bacteriophage as com-
pared to the group receiving only standard treatment the 
number of wound microorganisms was reduced by 63.64% 
(p <0.001) to the fifth day, and by 50% (p<0.001) to the 
tenth day. 
Microbiological analysis shows that the use of bacterio-
phage in the combined treatment resulted in a statistically 
significant reduction in the number of microorganisms in 
the wound compared with patients who received only tra-
ditional treatment, it indicates an increase of antibacterial 
effects in the wound with using of the proposed method of 
treatment. 
At the same time, when analyzing the dynamics of 
wound healing in patients of the third group treated with 
only bacteriophages because of multiple allergy to antibiot-
ics, compared with those of the first group, a statistically 
significant difference was not observed, but the results was 
not worse, which proves - monotherapy bacteriophages 
without the use of antibiotics has not a lower efficiency and 
therefore can be used as a separate treatment. 
Taking into account the results of research in the treat-
ment of inflammatory soft tissue lesions in patients with 
multiple allergy to antibiotics we can say that it is necessary 
to use bacteriophages as an alternative to antibiotics. 
 
Conclusions 
1. Clinical markers of wound healing with the use of bacte-
riophage as an alternative to antibiotic therapy in patients 
with multiple allergy to antibiotics does not statistically 
differ from these parameters in patients receiving standard 
antibiotic treatment. 
2. An alternative to antibiotic therapy in the treatment of 
inflammatory soft tissue diseases in patients with multiple 
allergy to antibiotics are bacteriophages. 
3. Combining of antibiotics and bacteriophages in treat-
ment of inflammatory and purulent soft tissue diseases 
reduces the wound healing time to 1,3 ± 0,74 days com-
pared with standard therapy.  
 
References 
1. Schenk M. Bacteriophages: an alternative to antibiotics? Dtsch Med 
Wochenschr. - 2014.- Vol.139, №4.- Р. 124-125. 
2. Reardon S. Phage therapy gets revitalized. Nature. - 2014. - Vol.510, 
№7503. – Р. 15-16. 
3. Cardona A.F., Wilson S.E. Skin and soft-tissue infections: a critical 
review and the role of telavancin in their treatment. Clin Infect Dis. 
2015 Sep 15;61 Suppl 2:S69-78. 
4. R. Wolcott, J. Costerton, D. Raoult, S. Cutler. The polymicrobial nature 
of biofilm infection. Clin. Microbiol. Infect. – 2013. – V.19. – P.107–
112. 
5. R.D.Wolcott, D.D. Rhoads, S.E. Dowd. Biofilms and chronic wound 
inflammation. J Wound Care. – 2008. – Vol. 17,  №8. – Р. 333–341. 
Ivashchenko D.M., et al. Surg Chron 2016; 21(4):201-206. 
206 
 
6. Sillankorva, S. Neubauer, P. Azaredo, J. Use of Bacteriophages to 
Control Biofilms. LAP Lambert Academic Publishing – 2011. -  
Saarbrücken, Germany  
7. Percival S. K.Cutting. Мicrobiology of wounds. CRC Press Taylor & 
Francis Group Boca Raton London New York. – 2010. – P.409 
8. G.A. James, E. Swogger, R. Wolcott [et al]. Biofilms in chronic wounds. 
Wound Rep Regen. – 2008. – Vol. 16, №1. – Р. 37–44. 
9. J.Azeredo, I.W.Sutherland. The Use of Phages for the Removal of 
Infectious Biofilms. Cur. Pharm. Biotech. – 2008. – Vol. 9, №4. – Р. 
261–266. 
10. Hawkey P.M. Multidrug-resistant Gram-negative bacteria: a product of 
globalization. J Hosp Infect. - 2015 - Apr; 89(4):241-7. 
11. Trubiano J, Phillips E. Antimicrobial stewardship's new weapon? A 
review of antibiotic allergy and pathways to 'de-labeling'. Curr Opin 
Infect Dis. – 2013 - Dec;26(6):526-37. 
12. Richter A.G., Nasser S.M., Krishna M.T. A UK national survey of investi-
gations for beta-lactam hypersensitivity - heterogeneity in practice 
and a need for national guidelines - on behalf of British Society for Al-
lergy and Clinical Immunology (BSACI). Clin Exp Allergy. - 2013 - 
Aug;43(8):941-9. 
13. Viertel T.M, Ritter K, Horz H.P. Viruses versus bacteria-novel ap-
proaches to phage therapy as a tool against multidrug-resistant path-
ogens. J Antimicrob Chemother. – 2014 - Sep;69(9):2326-36. 
14. Van Duin D, Paterson D.L. Multidrug-Resistant Bacteria in the Commu-
nity: Trends and Lessons Learned. Infect Dis Clin North Am. - 2016 - 
Jun;30(2):377-90. 
15. Hughes M.A. Wound infection: a knowledge deficit that needs ad-
dressing. Br J Nurs. – 2016 - Mar;25(6 Suppl):S46-51. 
 
 
Author for correspondence:  
Ivashchenko Dmytro,  
e-mail: Dimitrol.i@gmail.com, tel. +380955581081, Ukraine, Poltava, 
Sobornosti str. #61a, app. 8, post ind. 36014 
 
